HK1212443A1 - 凝血反應的評價方法 - Google Patents

凝血反應的評價方法

Info

Publication number
HK1212443A1
HK1212443A1 HK16100259.8A HK16100259A HK1212443A1 HK 1212443 A1 HK1212443 A1 HK 1212443A1 HK 16100259 A HK16100259 A HK 16100259A HK 1212443 A1 HK1212443 A1 HK 1212443A1
Authority
HK
Hong Kong
Prior art keywords
blood coagulation
coagulation reaction
evaluating blood
evaluating
reaction
Prior art date
Application number
HK16100259.8A
Other languages
English (en)
Inventor
添田哲弘
北澤剛久
島綠倫
Original Assignee
Chugai Pharmaceutical Co Ltd
Public University Corp Nara Medical Univers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd, Public University Corp Nara Medical Univers filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1212443A1 publication Critical patent/HK1212443A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6443Coagulation factor XIa (3.4.21.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/755Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96452Factor XI (3.4.21.27)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/22Haematology
    • G01N2800/224Haemostasis or coagulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK16100259.8A 2012-09-28 2016-01-12 凝血反應的評價方法 HK1212443A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012217925 2012-09-28
PCT/JP2013/075978 WO2014050926A1 (ja) 2012-09-28 2013-09-26 血液凝固反応の評価方法

Publications (1)

Publication Number Publication Date
HK1212443A1 true HK1212443A1 (zh) 2016-06-10

Family

ID=50388321

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100259.8A HK1212443A1 (zh) 2012-09-28 2016-01-12 凝血反應的評價方法

Country Status (14)

Country Link
US (1) US11078518B2 (zh)
EP (1) EP2902787B1 (zh)
JP (1) JP6284481B2 (zh)
KR (1) KR102134305B1 (zh)
CN (1) CN104937423B (zh)
BR (1) BR112015006634B1 (zh)
CA (1) CA2886326C (zh)
ES (1) ES2668455T3 (zh)
HK (1) HK1212443A1 (zh)
MX (1) MX358997B (zh)
PL (1) PL2902787T3 (zh)
RU (1) RU2683933C2 (zh)
TW (1) TWI609083B (zh)
WO (1) WO2014050926A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6013915B2 (ja) 2010-11-17 2016-10-25 中外製薬株式会社 血液凝固第viii因子の機能を代替する機能を有する多重特異性抗原結合分子
TWI700300B (zh) * 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第viii凝血因子(fviii)機能替代活性的物質之抗體
TWI701435B (zh) * 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定fviii的反應性之方法
CN114578068A (zh) * 2015-04-24 2022-06-03 公立大学法人奈良县立医科大学 血液受试体的凝固能力的评价方法、以及用于在该方法中使用的试剂、试剂盒及装置
JP7101351B2 (ja) 2016-04-28 2022-07-15 シスメックス株式会社 血液検体の分析方法、血液検体分析用試薬及び試薬キット、並びに血液検体分析装置
RU2699798C1 (ru) * 2019-05-22 2019-09-11 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Способ выявления дефицитов факторов свертывания крови методом тромбоэластометрии
JP6883899B1 (ja) * 2020-12-07 2021-06-09 株式会社血栓トランスレーショナルリサーチラボ 血液凝固検査試薬、および血液凝固検査方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP2746386B2 (ja) * 1988-09-07 1998-05-06 清水製薬株式会社 全血を用いた血液凝固能検査法
DK162233C (da) * 1989-11-09 1992-03-16 Novo Nordisk As Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
EP0814159B1 (en) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
EP0746609A4 (en) 1991-12-17 1997-12-17 Genpharm Int NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
CA2133983C (en) 1992-04-27 2004-04-06 Stephen E. Zweig Test article and method for performing blood coagulation assays
CA2140638C (en) 1992-07-24 2010-05-04 Raju Kucherlapati Generation of xenogeneic antibodies
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
FR2707189B1 (fr) 1993-07-09 1995-10-13 Gradient Ass Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé.
KR100261941B1 (ko) 1994-07-13 2000-07-15 나가야마 오사무 사람의 인터루킨-8에 대한 재구성 사람항체
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
AT405692B (de) * 1997-03-27 1999-10-25 Immuno Ag Reagens zur bestimmung der aptt
SK14812000A3 (sk) 1998-04-03 2001-08-06 Chugai Seiyaku Kabushiki Kaisha Chimérny reťazec protilátky, chimérna protilátka, v oblasť, humanizovaný reťazec protilátky, humanizovaná protilátka, dna, expresný vektor, hostiteľ, spôsob prípravy a liečivo
DE60140474D1 (de) 2000-09-08 2009-12-24 Univ Zuerich Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
EP1356075A4 (en) 2000-10-16 2005-04-13 Compound Therapeutics Inc PROTEIN EQUIPMENT FOR ANTIBODY MIMETICS AND OTHER TIE PROTEINS
US20030157561A1 (en) 2001-11-19 2003-08-21 Kolkman Joost A. Combinatorial libraries of monomer domains
US7297336B2 (en) * 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
AU2003271174A1 (en) 2003-10-10 2005-04-27 Chugai Seiyaku Kabushiki Kaisha Double specific antibodies substituting for functional protein
US20050164301A1 (en) 2003-10-24 2005-07-28 Avidia Research Institute LDL receptor class A and EGF domain monomers and multimers
DE102005008066A1 (de) 2005-02-22 2006-08-24 Haemosys Gmbh Verfahren zur Bestimmung der Gesamtgerinnungsaktivität einer Blut- oder Plasmaprobe
EP2824183B1 (en) * 2005-04-08 2020-07-29 Chugai Seiyaku Kabushiki Kaisha Methods for producing bispecific antibodies
CN101415445A (zh) * 2006-03-31 2009-04-22 巴克斯特国际公司 聚乙二醇化的因子ⅷ
MX2008012600A (es) 2006-03-31 2008-12-12 Baxter Int Factor viii pegilado.
JP6013915B2 (ja) 2010-11-17 2016-10-25 中外製薬株式会社 血液凝固第viii因子の機能を代替する機能を有する多重特異性抗原結合分子
BR112014003787A2 (pt) 2011-08-23 2020-10-27 Synapse B.V. inibidores termoestáveis de ativação do sistema de coagulação sanguínea por contato com superfícies estranhas

Also Published As

Publication number Publication date
KR20150068406A (ko) 2015-06-19
CN104937423A (zh) 2015-09-23
JPWO2014050926A1 (ja) 2016-08-22
MX358997B (es) 2018-09-12
EP2902787B1 (en) 2018-03-28
RU2015115277A (ru) 2016-11-20
BR112015006634B1 (pt) 2022-06-14
US20150240287A1 (en) 2015-08-27
CA2886326A1 (en) 2014-04-03
BR112015006634A2 (zh) 2017-09-05
CA2886326C (en) 2021-11-02
JP6284481B2 (ja) 2018-02-28
ES2668455T3 (es) 2018-05-18
EP2902787A4 (en) 2016-03-23
KR102134305B1 (ko) 2020-07-15
TWI609083B (zh) 2017-12-21
US11078518B2 (en) 2021-08-03
MX2015003740A (es) 2015-09-23
WO2014050926A1 (ja) 2014-04-03
RU2683933C2 (ru) 2019-04-03
TW201418470A (zh) 2014-05-16
CN104937423B (zh) 2017-05-24
PL2902787T3 (pl) 2018-08-31
EP2902787A1 (en) 2015-08-05

Similar Documents

Publication Publication Date Title
HK1213944A1 (zh) 用於靶向基因組分析
ZA201501833B (en) Method for obtaining 1-kestone
EP2814984A4 (en) MIRNA ANALYSIS PROCEDURE
EP2906697A4 (en) METHODS OF MONITORING C9ORF72 EXPRESSION
LT3305918T (lt) Būdai, skirti epigenetinių sekų sudarymui
EP2833144A4 (en) METHOD OF DETECTING BIOLOGICAL SUBSTANCE
EP2825212A4 (en) IMPROVED STERILIZATION PROCESS
HK1212443A1 (zh) 凝血反應的評價方法
GB2518081B (en) Providing an ID-verified blood test
EP2869764C0 (en) SYSTEM AND METHOD FOR MEASURING BLOOD PARAMETERS
EP2814796A4 (en) METHOD FOR PRODUCING TETRAFLUORPROPES
HUP1200607A2 (en) Diagnostic method
EP2939994A4 (en) PROCESS FOR CLEANING TETRAFLUORPROPES
HK1213992A1 (zh) 用於評估醫學測量曲線的方法
EP2833116A4 (en) METHOD FOR ASSESSING A COAL INTERMEDIATE TERMINATION
EP2685257A4 (en) METHOD OF ANALYSIS
EP2832387A4 (en) MANUFACTURING METHOD FOR MEDICAL INSTRUMENT, MEDICAL INSTRUMENT
EP2873730A4 (en) BIOLOGICAL PROCESS FOR THE PREPARATION OF CIS-5-HYDROXY-L-PIPECOLIC ACID
HK1201691A1 (zh) 殺菌方法
GB2517113B (en) Method involving pre-treating medical instruments
IL227295A0 (en) diagnostic method
GB201218341D0 (en) Diagnostic method
EP2803732A4 (en) PROCESS FOR PREPARING A CHEMICAL FABRIC
GB201204071D0 (en) Polymer treatment method
EP2860520A4 (en) METHOD FOR DIAGNOSING MATERIAL